ABBOTT LABORATORIES (NYSE: ABT)

View Portfolio
Back to Investopedia
Back to Investopedia




$53.39 0.04 (0.07%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
57.36
52-Week Low Price
41.27
Avg Volume (3 Mo.)
7.00 M
Market Cap
83.48 B
P/E Ratio (TTM)
14.6
Diluted EPS (TTM)
3.32
Shares
1546.74 M
Dividend Rate ($) / (%)
1.60/3.00
91%
9%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : -6% - ABT has underperformed the S&P 500 by 32%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
PFIZER INC (PFE) $17.85 -  $0.01(0.06%)144.93 B
NOVARTIS AG ADS (NVS) $53.54 -  $0.46(0.87%)120.96 B
MERCK & COMPANY; INC. (MRK) $36.33 -  $0.26(0.71%)113.83 B
GLAXOSMITHKLINE PLC (GSK) $38.46 -  $0.34(0.90%)107.74 B
SANOFI-AVENTIS ADS (SNY) $36.29 -  $0.38(1.06%)93.43 B
ASTRAZENECA PLC (AZN) $44.12 -  $0.99(2.30%)62.34 B
AMGEN INC (AMGN) $57.10 -  $0.36(0.63%)58.38 B
TEVA PHARMACEUTICAL LTD (TEVA) $57.14 -  $0.22(0.39%)51.77 B
BRISTOL-MYERS SQUIBB CO (BMY) $24.20 -  $0.24(1.00%)47.48 B
GILEAD SCIENCES INC (GILD) $46.31 -  $0.22(0.48%)41.74 B
As of February 09, 2010 at 4:15 PM ET
STOCK ANALYSIS
Stock Analysis
A Good Start To Earnings Season? (AAPL, COP, WFT, ABT)
The number of companies beating consensus estimates in Q4 earnings season hit a 10-year high, but stocks still retr...
Stock Analysis
A Look Back On Deals In 2009 (BRK.A, BNI, PHM, PFE, DIS, MVL)
2009 was an exciting year for mergers, buyouts, industry consolidation plays and hostile takeover attempts.
Stock Analysis
4 Companies Raising Earnings Guidance (IBM, CSIQ, PETM, ABT)
Third quarter earning season is off to a good start, as a record number of companies have raised guidance.
Stock Analysis
3 Slow-and-Steady Healthcare Stocks (JNJ, BSX, ABT, BAX)
J&J, Abbot and Baxter are looking robust, despite the ailing economy.
Stock Analysis
Long-Term Flu Plays (BCRX, INO, NVAX, GSK, NVS, SNY, JNJ, ABT)
Flu vaccine shares still have long-term appeal.
View All Stock Analysis
ABT RELATED HEADLINES
arrow
Two Pharmas
Featuring Wallace Forbes and Damien Conover.
Forbes.com 2/4/2010
arrow
Ten Questions About High Cholesterol
The biggest heart risk factor still mystifies top scientists. Here's what you need to know.
Forbes.com 2/3/2010
arrow
Abbott Laboratories (ABT) Makes Investors Observer Analysts Favorites List
Abbott Laboratories (NYSE: ABT) closed yesterday at $54.44. So far the stock has hit a 52-week low of $41.27 and 52-week high of $57.39. Abbott Laboratories stock has been showing support around 52.68 and resistance in the 55.48 range. Technical indicators for the stock are Bullish and S&P gives ABT a positive 4 STAR (out of 5) buy rating. ABT appears on the Investors Observer Analysts Favorites list. For a hedged play on this stock, look at a May '10 55 covered call for a net debit in the $52.57 area. That is also the break even stock price for this trade. This covered call has a 108 day duration, provides 3.43% d...
At Market Intelligence Center 2/3/2010
arrow
A Good Start To Earnings Season? (AAPL, COP, WFT, ABT)
The number of companies beating consensus estimates in Q4 earnings season hit a 10-year high, but stocks still retreated over weak macro news.
at Investopedia Advisor 1/27/2010
arrow
Abbott Laboratories (ABT) Fourth Quarter Earnings Preview
Abbott Laboratories (NYSE: ABT) opened at $54.57. So far today, the stock has hit a low of $54.29 and a high of $54.67. ABT is now trading at $54.40, down $0.30 (-0.55%). The stock hit its 52-Week high of $57.39 in February and set its 52-Week low of $41.27 in May. Abbott is trading lower today ahead of tomorrow's earnings report. Going into tomorrow's report, analysts are expecting to see the compan...
At Market Intelligence Center 1/26/2010
arrow
Bringing Atkins Back From The Dead
Will a healthier pitch help this diet company make a comeback?
Forbes.com 1/25/2010
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1